Plasma and Dietary Linoleic Acid and 3-Year Risk of Type 2 Diabetes After Myocardial Infarction: A Prospective Analysis in the Alpha Omega Cohort.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
02 2020
Historique:
received: 26 07 2019
accepted: 27 10 2019
pubmed: 16 11 2019
medline: 27 10 2020
entrez: 16 11 2019
Statut: ppublish

Résumé

To study plasma and dietary linoleic acid (LA) in relation to type 2 diabetes risk in post-myocardial infarction (MI) patients. We included 3,257 patients aged 60-80 years (80% male) with a median time since MI of 3.5 years from the Alpha Omega Cohort and who were initially free of type 2 diabetes. At baseline (2002-2006), plasma LA was measured in cholesteryl esters, and dietary LA was estimated with a 203-item food-frequency questionnaire. Incident type 2 diabetes was ascertained through self-reported physician diagnosis and medication use. Hazard ratios (with 95% CIs) were calculated by Cox regressions, in which dietary LA isocalorically replaced the sum of saturated (SFA) and Mean ± SD circulating and dietary LA was 50.1 ± 4.9% and 5.9 ± 2.1% energy, respectively. Plasma and dietary LA were weakly correlated (Spearman In our cohort of post-MI patients, plasma LA was inversely related to type 2 diabetes risk, whereas dietary LA was not related. Further research is needed to assess whether plasma LA indicates metabolic state rather than dietary LA in these patients.

Identifiants

pubmed: 31727685
pii: dc19-1483
doi: 10.2337/dc19-1483
pmc: PMC6971780
doi:

Substances chimiques

Biomarkers 0
Dietary Fats 0
Trans Fatty Acids 0
Linoleic Acid 9KJL21T0QJ

Banques de données

ClinicalTrials.gov
['NCT00127452']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

358-365

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL076200
Pays : United States

Informations de copyright

© 2019 by the American Diabetes Association.

Références

Diabetes Care. 2019 Aug;42(8):1406-1413
pubmed: 31182488
Am J Clin Nutr. 2011 Aug;94(2):520-6
pubmed: 21593505
Lancet Diabetes Endocrinol. 2017 Dec;5(12):965-974
pubmed: 29032079
Am J Clin Nutr. 2011 Jan;93(1):127-42
pubmed: 20980488
Stat Med. 2010 Apr 30;29(9):1037-57
pubmed: 20087875
Eur Heart J. 2015 May 14;36(19):1163-70
pubmed: 25586123
N Engl J Med. 2010 Nov 18;363(21):2015-26
pubmed: 20929341
Diabetes Care. 2001 Sep;24(9):1528-35
pubmed: 11522694
Am Heart J. 2010 Apr;159(4):539-546.e2
pubmed: 20362710
Prog Lipid Res. 2008 Sep;47(5):348-80
pubmed: 18435934
Lipids Health Dis. 2016 Sep 27;15(1):167
pubmed: 27671740
Am J Clin Nutr. 2015 Dec;102(6):1527-33
pubmed: 26490494
Am J Clin Nutr. 2001 Jun;73(6):1019-26
pubmed: 11382654
Am J Clin Nutr. 2010 Nov;92(5):1214-22
pubmed: 20861175
Am J Clin Nutr. 2007 Jul;86(1):189-97
pubmed: 17616780
Ann Nutr Metab. 2013;63(3):229-38
pubmed: 24192557
Am J Clin Nutr. 1993 Oct;58(4):489-96
pubmed: 8379504
Nutr Metab Cardiovasc Dis. 2019 Apr;29(4):343-350
pubmed: 30718141
Int J Food Sci Nutr. 1995 May;46(2):117-23
pubmed: 7621083
Am J Clin Nutr. 2015 May;101(5):1065-80
pubmed: 25832335
Diabetes. 1981 Sep;30(9):773-80
pubmed: 6266903
Br J Nutr. 2012 Jun;107 Suppl 2:S214-27
pubmed: 22591895
Br J Nutr. 2016 Nov 15;:1-9
pubmed: 27842617
Diabetes Care. 2002 Mar;25(3):417-24
pubmed: 11874924
J Gastroenterol Hepatol. 2016 May;31(5):936-44
pubmed: 26667191
BMJ Open Diabetes Res Care. 2019 Feb 8;7(1):e000585
pubmed: 30899527
J Clin Invest. 1996 May 1;97(9):2081-91
pubmed: 8621798
PLoS Med. 2016 Jul 19;13(7):e1002094
pubmed: 27434045
Clin Chem. 2003 Apr;49(4):652-5
pubmed: 12651820
Lipids Health Dis. 2017 Apr 4;16(1):68
pubmed: 28372558
J Clin Epidemiol. 1997 May;50(5):541-6
pubmed: 9180646
Diabetologia. 2015 Nov;58(11):2533-44
pubmed: 26277381
J Clin Invest. 2005 May;115(5):1343-51
pubmed: 15864352
Am J Clin Nutr. 2017 Sep 1;106(3):895-901
pubmed: 28793994
PLoS One. 2015 Jul 08;10(7):e0131434
pubmed: 26154343

Auteurs

Kamalita Pertiwi (K)

Division of Human Nutrition and Health, Wageningen University, Wageningen, the Netherlands kamalita.pertiwi@wur.nl.

Anne J Wanders (AJ)

Unilever Research and Development, Vlaardingen, the Netherlands.

Marjolein C Harbers (MC)

Division of Human Nutrition and Health, Wageningen University, Wageningen, the Netherlands.

Leanne K Küpers (LK)

Division of Human Nutrition and Health, Wageningen University, Wageningen, the Netherlands.

Sabita S Soedamah-Muthu (SS)

Division of Human Nutrition and Health, Wageningen University, Wageningen, the Netherlands.

Janette de Goede (J)

Division of Human Nutrition and Health, Wageningen University, Wageningen, the Netherlands.

Peter L Zock (PL)

Unilever Research and Development, Vlaardingen, the Netherlands.

Johanna M Geleijnse (JM)

Division of Human Nutrition and Health, Wageningen University, Wageningen, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH